Education
About Us
Working with TipRanks
Follow Us
Sofwave Medical Ltd. (IL:SOFW)
:SOFW
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,300.00 - 3,921.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.27B
Enterprise Value391.79M
Total Cash (Recent Filing)₪26.52M
Total Debt (Recent Filing)₪2.00M
Price to Earnings (P/E)71.1
Beta0.23
Next Earnings
Mar 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.30
Shares Outstanding36,100,570
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio0.69
Price to Book (P/B)5.90
Price to Sales (P/S)2.43
P/FCF Ratio-54.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Rapid Revenue GrowthSustained TTM revenue growth of ~82.5% shows durable market adoption of Sofwave's ultrasound platform. Over a multi-month horizon this supports expanding clinic penetration, a growing installed base, and operating leverage potential that can fund R&D, training and commercial scale.
High Gross MarginsA ~76% gross margin reflects strong product economics for devices and consumables. Structurally high gross margins provide a lasting cushion to absorb SG&A, support investment in clinical evidence and training, and make sustainable operating profitability achievable as volume scales.
Low Leverage With Improving Cash GenerationVery low debt-to-equity and a 326% TTM free cash flow improvement indicate a resilient balance sheet and improving cash conversion. This structural strength increases financial flexibility for capex, partnerships or M&A and reduces refinancing risk during multi-month cycles.
Bears Say
Negative Net Profitability And ROEDespite strong revenue and gross margins, Sofwave reports a negative net margin and negative ROE. Persisting unprofitability hampers long-term shareholder value creation and implies the company must deliver sustained operating leverage or cut costs to convert top-line strength into durable profits.
Limited Organizational ScaleA headcount of 126 suggests constrained commercial, clinical and support capacity versus larger peers. Limited scale can raise per-unit SG&A, slow geographic roll-out and make margin improvement heavily dependent on rapid personnel and distribution scaling over the coming months.
Concentrated Revenue Model Reliant On Device SalesReliance on capital equipment and consumable sales creates lumpy, cycle-driven revenue and limits predictability. Unless recurring service/maintenance or consumable attachment rates grow materially, revenue and margin stability will remain sensitive to replacement cycles and procedure demand.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1300.00 and its highest was 3921.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.27B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is Mar 11, 2026 which is in 6 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on Nov 04, 2025. The company reported 9.3 earnings per share for the quarter, beating the consensus estimate of N/A by 9.3.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,100,570 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 9.3 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.022%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.